Boston Trust Walden Corp Raises Position in Colgate-Palmolive Company $CL

Boston Trust Walden Corp grew its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 4.6% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 170,118 shares of the company’s stock after purchasing an additional 7,434 shares during the quarter. Boston Trust Walden Corp’s holdings in Colgate-Palmolive were worth $13,443,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the company. KLP Kapitalforvaltning AS increased its holdings in shares of Colgate-Palmolive by 2.2% during the 4th quarter. KLP Kapitalforvaltning AS now owns 629,523 shares of the company’s stock worth $49,745,000 after buying an additional 13,600 shares during the last quarter. FORM Wealth Advisors LLC acquired a new stake in shares of Colgate-Palmolive during the 4th quarter worth $303,000. Universal Beteiligungs und Servicegesellschaft mbH increased its holdings in shares of Colgate-Palmolive by 5.1% during the 4th quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 755,418 shares of the company’s stock worth $60,138,000 after buying an additional 36,398 shares during the last quarter. TABR Capital Management LLC acquired a new stake in shares of Colgate-Palmolive during the 4th quarter worth $425,000. Finally, Salomon & Ludwin LLC increased its holdings in shares of Colgate-Palmolive by 2.2% during the 4th quarter. Salomon & Ludwin LLC now owns 10,318 shares of the company’s stock worth $794,000 after buying an additional 225 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have recently commented on CL. Morgan Stanley upped their price objective on Colgate-Palmolive from $87.00 to $100.00 and gave the stock an “overweight” rating in a report on Monday, February 2nd. Evercore upped their price target on shares of Colgate-Palmolive from $94.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, February 2nd. Piper Sandler decreased their price target on shares of Colgate-Palmolive from $96.00 to $92.00 and set an “overweight” rating for the company in a research report on Wednesday, April 8th. JPMorgan Chase & Co. decreased their price target on shares of Colgate-Palmolive from $97.00 to $95.00 and set an “overweight” rating for the company in a research report on Friday, April 17th. Finally, Barclays decreased their price target on shares of Colgate-Palmolive from $88.00 to $79.00 and set an “equal weight” rating for the company in a research report on Tuesday, April 14th. Twelve analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $95.88.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $82.25 on Thursday. The company has a debt-to-equity ratio of 18.82, a current ratio of 0.83 and a quick ratio of 0.54. The firm has a 50-day moving average of $89.27 and a two-hundred day moving average of $83.82. The stock has a market cap of $65.99 billion, a P/E ratio of 31.39, a PEG ratio of 4.17 and a beta of 0.34. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $99.33.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. The company had revenue of $5.23 billion during the quarter, compared to analysts’ expectations of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the prior year, the company posted $0.91 EPS. On average, research analysts expect that Colgate-Palmolive Company will post 3.87 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be given a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date of this dividend is Monday, April 20th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.52. Colgate-Palmolive’s dividend payout ratio is currently 80.92%.

Insider Activity

In other Colgate-Palmolive news, COO Panagiotis Tsourapas sold 35,000 shares of the company’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $94.61, for a total value of $3,311,350.00. Following the completion of the transaction, the chief operating officer directly owned 10,415 shares of the company’s stock, valued at $985,363.15. This represents a 77.07% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider John Hazlin sold 20,989 shares of the company’s stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the completion of the transaction, the insider directly owned 17,645 shares of the company’s stock, valued at approximately $1,663,041.25. The trade was a 54.33% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 184,683 shares of company stock valued at $17,486,693. Corporate insiders own 0.43% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.